Kathryn Haviland
2018
Compensation breakdown
| Non-Equity Incentive Plan | $163,317 |
|---|---|
| Option Awards | $2,037,606 |
| Salary | $392,589 |
| Other | $8,250 |
| Total | $2,601,762 |
Haviland received $2M in option awards, accounting for 78% of the total pay in 2018.
Haviland also received $163.3K in non-equity incentive plan, $392.6K in salary and $8.3K in other compensation.
Rankings
In 2018, Kathryn Haviland's compensation ranked 4,493rd out of 14,244 executives tracked by ExecPay. In other words, Haviland earned more than 68.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,493 out of 14,244 | 69th |
Division Manufacturing | 1,683 out of 5,765 | 71st |
Major group Chemicals And Allied Products | 605 out of 2,128 | 72nd |
Industry group Drugs | 506 out of 1,817 | 72nd |
Industry Pharmaceutical Preparations | 394 out of 1,391 | 72nd |
Pay ratio
| Kathryn Haviland's Pay | $2,601,762 |
|---|---|
| Median Employee's Pay | $398,087 |
| Pay Ratio | to 1 |
In 2018, the annual total compensation of Kathryn Haviland was $2,601,762.
The annual total compensation of the median employee at Blueprint Medicines was $398,087.
The ratio of Kathryn Haviland's pay to the pay of median employee was therefore to one.
Haviland's colleagues
We found five more compensation records of executives who worked with Kathryn Haviland at Blueprint Medicines in 2018.
2018
Jeffrey Albers
Blueprint Medicines
Chief Executive Officer
2018
Christina Rossi
Blueprint Medicines
Chief Commercial Officer
2018
Anthony Boral
Blueprint Medicines
Chief Medical Officer
2018
Tracey McCain
Blueprint Medicines
Chief Legal and Compliance Officer
2018
Michael Landsittel
Blueprint Medicines